Sagun Medixsystem Opc Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.00 M
- Revenue Growth 4.65%
- Profit Growth -41.11%
- Ebitda 38.05%
- Net Worth 5.17%
- Total Assets 15.43%
About Sagun Medixsystem Opc
Sagun Medixsystem Opc Private Limited (SMOPL) is a Company incorporated in India on 11 December 2014 and has a history of Ten years and two months. Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.00 M.
Anjali serves as a director at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52311DL2014OPC273994
-
Company No.
273994
-
Incorporation Date
11 Dec 2014
-
Date of AGM
-
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
What products or services does Sagun Medixsystem Opc Private Limited offer?
Sagun Medixsystem Opc Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Dermatology Equipment, CPAP, BiPAP Machine & Accessories, Optical, Laser Instruments & Devices, Medical Lasers, Orthopedic Trauma Implants, Nasal Implants, Antiparasitic Drug, Ivermectin Tablets, CPAP Mask.
Who are the key members and board of directors at Sagun Medixsystem Opc?
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anjali
|
Director | 03-Dec-2015 | Current |
Financial Performance of Sagun Medixsystem Opc.
Sagun Medixsystem Opc Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.65% increase. The company also saw a substantial fall in profitability, with a 41.11% decrease in profit. The company's net worth moved up by a moderate rise of 5.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sagun Medixsystem Opc?
In 2023, Sagun Medixsystem Opc had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2019 | Others | ₹1.00 M | Open |
How Many Employees Work at Sagun Medixsystem Opc?
Unlock and access historical data on people associated with Sagun Medixsystem Opc, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sagun Medixsystem Opc, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sagun Medixsystem Opc's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
